MYGN Financial Facts

Operating income: 83M
Earnings per basic share: 0.67
See Full Income Statement

Accounts payable: 17.6M
Equipment: 73.57M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 5/2/14 *Est. EPS Growth Rate +57.1% *Last Qtr.
Average EPS % Beat Rate +30.6% Revenue Growth Rate +36.9% *Last Qtr.
Average % Move 1-Wk after EPS +0.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/4/14 Q214 $0.66$0.46 +$0.20$204.06M$176.02M +39.7% Details
11/5/13 Q114 $0.68$0.46 +$0.22$202.47M$167.64M +49.9% Details
8/13/13 Q413 $0.53$0.44 +$0.09$174.1M$159.87M +25.2% Details
2/5/13 Q213 $0.42$0.38 +$0.04$149.1M$143.71M +39.9% Details
11/5/12 Q113 $0.36$0.32 +$0.04$133.44M$129.43M +41.4% Details
5/7/13 Q113 $0.46$0.40 +$0.06$156.5M$148.25M +34.2% Details
1/31/12 Q212 $0.33$0.31 +$0.02$122.8M$115.28M = +60.5% Details
8/14/12 Q212 $0.34$0.34 $0.00$133M$131.85M = +49.1% Details